Avalyn Pharma reports Q1 2026 financial results

Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• medium

  Avalyn Pharma announced financial results for the quarter ended March 31, 2026. Detailed figures are in the attached press release (Exhibit 99.1), not in the 8-K body itself.

  Item 2.02 verify on EDGAR →
• medium

  This is a routine quarterly earnings disclosure. Investors should review the full press release for revenue, expenses, cash position, and management commentary.

  8-K: Earnings verify on EDGAR →